Drug Studied at UTHSCT Offers Triple Effectiveness Rate of Alternatives
A new drug studied by researchers at The University of Texas Health Science Center at Tyler (UTHSCT) has been shown to triple the treatment success rate in patients with treatment refractory Mycobacterium avium complex (MAC), a debilitating lung disease.”We have been treating MAC patients for decades without having a drug specifically approved by the U.S. […]